Cardiometabolic
The case for ApoB-first lipid management
Why measuring particle count outperforms LDL-C for predicting cardiovascular risk — and how we use it in practice.
8 min
Long-form perspectives prepared by BioSphere Human Optimization and reviewed by BioSphere-affiliated medical advisors. Every claim is sourced; every recommendation is contextual.
A strategic, non-clinical perspective on TRT, BHRT, thyroid health, menopause, and the future of proactive hormone optimization.
A systems-level perspective on integrating diagnostics, clinical decision-making, therapeutics, and execution into a coordinated architecture for measurable outcomes.
Why measuring particle count outperforms LDL-C for predicting cardiovascular risk — and how we use it in practice.
Lactate kinetics, not a Garmin zone, define the training stimulus. A practical framework for prescribing it.